ISRCTN48336189Active, not recruitingUnknown
Efficacy of low dosage yeast beta-glucan 1,3/1,6 on respiratory infection, fatigue, immune markers and gut health among adults with moderate stress
Mead Johnson Nutrition Malaysia0 sites200 target enrollmentStarted: August 4, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Current inclusion criteria as of 16/01/2024:
- •1. 18-59 years old
- •2. In a stressful environment
- •3. Scoring 14-26 (moderate stress) on the Perceived Stress Scale (PSS-10)
- •4. Symptoms of common colds in the past 6 months
- •5. Willing to comply with protocol requirements
- •Previous inclusion criteria:
- •1. 18-60 years old
- •2. In a stressful environment
- •3. Scoring 14-26 (moderate stress) on the Perceived Stress Scale (PSS-10)
- •4. Symptoms of common colds in the past 6 months
- •5. Willing to comply with protocol requirements
Exclusion Criteria
- •1. Participant on immunosuppressant (i.e., steroids)
- •2. Use of immune-modifying medications or dietary supplements affecting the immune system (at least 2 weeks of washing period for inclusion)
- •3. Any autoimmune or health concerns
- •4. Uncontrolled comorbidities including diabetes, hypertension, cardiovascular disease, chronic kidney disease, chronic liver disease, active malignancy, endocrine disorder and cancer
- •5. Uncontrolled chronic respiratory illness including allergic rhinitis or asthma, presence of nasal ulcers/polyps
- •6. Body temperature >38?C at study commencement
- •7. Pregnant/lactating female
- •8. On specific dietary requirements (diabetic diet/low salt diet/etc)
- •9. On prebiotics or probiotics supplementation (at least 2 weeks of washing period for inclusion)
- •10. On antibiotics washing period within 2 weeks for inclusion
- •11. Disabilities individuals- long-term physical, mental, intellectual and sensory impairment
- •12. Individuals without symptoms of common colds for the past 6 months
- •13. Allergy to yeast, oat, wheat, barley
- •14. Influenza vaccination for the past 1 year
- •15. Pneumococcal vaccine for the past 5 years
- •16. Participate in another research study
Investigators
Similar Trials
Completed
Phase 1
Effectiveness of beta-glucan supplementation to interleukine-6, interleukine-10 and tumour necrosis factor alpha in overweight and obese subjectInflammationInterleukinTumour nacrosis factorTCTR20140604001Core Chematis Co., Ltd44
Not yet recruiting
Unknown
Clinical evaluation study of Beta-glucan assayinvasive fungal infectionsJPRN-UMIN000050121Osaka Metropolitan University900
Completed
Phase 3
Effect of Yeast Beta Glucan (Saccharomyces cerevisiae) compared to a placebo on cold and flu symptoms in an Adult Population – A double blind, randomised controlled trial.Common ColdACTRN12620001285943RDC Global Pty Ltd.240
Completed
Not Applicable
Impact of brewer's yeast (beta-glucan supplementation) on body status and muscle damage after exercise stressRecovery from stressful exerciseISRCTN16680414Increnovo LLC31
Completed
Not Applicable
Polycan in Combination With Glucosamine for Treatment of Knee OsteoarthritisOsteoarthritis of the KneeNCT03717714Vietstar Biomedical Research90